Loading organizations...
Key people at Opo Bio.
Opo Bio develops and supplies advanced cell lines and bio-based ingredients for the cultivated meat industry, expanding into cosmetic and medical applications with Opo-Collagen. Leveraging synthetic biology and biomanufacturing, the company creates high-performance biomaterials. Their approach establishes robust, multi-species cell banks, providing essential building blocks for diverse biomanufacturing processes.
Co-founded by Olivia Ogilvie and University of Auckland scientist Laura Domigan, Opo Bio emerged from over a decade of university research. Their insight identified the critical need for superior cell lines to scale cultivated meat. This academic foundation, with a pioneering cell line portfolio, propelled translating scientific breakthroughs into an industry-focused venture.
Opo Bio serves a global clientele in biotech ingredients, including cultivated meat producers and cosmetic/medical product developers. The company’s vision is to be a leading supplier of next-generation bio-based ingredients, establishing a vital supply chain for cultivated meat, and empowering partners to achieve scale. Through specialized cell line development, Opo Bio delivers biomaterials excelling in performance, sustainability, and safety.
Key people at Opo Bio.
Opo Bio is a New Zealand–based biotechnology company that develops and supplies cell lines ("starting cells") for biomanufacturing applications such as cultivated meat and collagen, positioning itself as a commercial cell-bank and cell-line development partner for the emerging cellular agriculture industry[3][1].
High-Level overview
Origin story
Core differentiators
Role in the broader tech/biotech landscape
Quick take & future outlook
Quick final note tying back: Opo Bio aims to be the "seed" supplier for a scaling biomanufacturing sector—solving a concrete technical bottleneck at a time when cultivated‑meat and biomaterials companies need standardized, scalable starting cells to move from prototypes to commercial production[3][1].
Limitations: Public sources about Opo are limited to the company website and regional startup directories; detailed financials, client lists, pricing, and independent performance metrics were not available in the cited materials[3][1][4].